All Staphylococcus aureus articles
-
News$7 Million grant to tackle lung infections through innovative probiotic treatment
The PROTECT project seeks to combat lung infections by assembling a community of beneficial lung microbes that can outcompete harmful pathogens.
-
NewsScientists can pinpoint bacterial needle in haystack using fluorescence
Bacterial troublemakers are able to survive antibiotics and are not detected by diagnostic antibiotic resistance testing. A new method has been developed to look at single bacteria and to find the antibacterial resistant ones, or the troublemakers, among them.
-
NewsResearchers to study how much MRSA is lurking in the air in hospitals
Scientists are working to minimize health care workers’ exposure to MRSA, or methicillin-resistant Staphylococcus aureus, a type of staph bacteria that’s become resistant to many of the antibiotics used to treat ordinary staph infections.
-
NewsInnovative implant material combines osteogenic and antibacterial properties for superior bone repair
A new study introduces a novel polyetheretherketone (PEEK)-based implant material that not only promotes bone growth but also possesses potent antibacterial capabilities.
-
NewsMulti-disciplinary team awarded $3.9 million to study mixed fungal-bacterial infections
A multi-disciplinary team was recently awarded $3.9 million from the National Institute of Allergy and Infectious Diseases for a project aimed at unravelling intricate mysteries surrounding complex fungal-bacterial infections.
-
NewsNasal microbiome: friendly pirates deprive multi-resistant bugs of iron
A new study reveals that whether dangerous staphylococci survive in the nose depends on what other bacteria are present – and how they obtain iron.
-
NewsHuman clinical study launched using phage lysin to eliminate staph in the nasal microbiome
A “first-in-human” study with the novel drug candidate HY-133 began on 10 July with the recruitment of clinically healthy volunteers who tested positive for Staphylococcus aureus colonisation of the nose.
-
NewsCopper oxide nanoparticles to counter pathogens are synthesized from mango
Researchers have synthesized green copper oxide nanoparticles from Mangifera indica leaf extract. They showed potent activity against gram-positive and negative bacteria, as well as fungicidal effects on persimmon fruit pathogens.
-
NewsResearch reveals how the body unwittingly rolls out the red carpet for staph
Scientists have shown that our bodies can unwittingly create conditions that usher staph, including MRSA, right into danger zones such as the airways or heart.
-
NewsEngineered nanovesicles from activated neutrophils show promise in treating infected wounds
A recent study has developed nanovesicles (NVs) from activated neutrophils, showcasing their ability to perform molecular debridement and accelerate healing in infectious wounds.
-
NewsPhage‐display tech boosts targeting ability of antimicrobial peptides against Staphylococcus aureus
Antibiotics are widely used in clinical treatment and animal production as an effective means to combat microbial infections. Antimicrobial peptides, as potential alternatives to antibiotics, have shown promising applications. Source: CDC/ Matthew J. Arduino/ Janice Haney Carr Under a very high magnification of 20,000x, this scanning electron micrograph ...
-
NewsScientists discover how to improve vaccine responses to potentially deadly bacterium
Researchers have shown in an animal model that targeting a key suppressive immune molecule (IL-10) during the delivery of a vaccine improves the ability of the vaccine to protect against infection.
-
NewsBerberine could treat eczema-exacerbated staph infections
Eczema, a skin inflammatory disease that causes dry, itchy and inflamed skin, affects millions worldwide. Eczema is associated with an altered skin microbiome and higher colonization by Staphylococcus aureus. Source: NIAID/NIH Scanning electron micrograph of methicillin-resistant Staphylococcus aureus(MRSA, brown) surrounded by cellular debris. A new study, ...
-
NewsInnovative phage lysin HY-133 enters phase I clinical study
HYpharm’s innovative preventive agent HY-133 has reached the first clinical trial phase. HY-133 is specifically effective against Staphylococcus aureus including multi-resistant strains and is intended to combat its colonisation in the nose.
-
NewsTwo types of polymicrobial infections in chronic lung diseases
Chronic lung diseases are often accelerated and exacerbated by polymicrobial infections. An international study team led by MedUni Vienna has identified two types of these so-called dysbioses in cystic fibrosis. They display distinct ecology and are also likely to respond differently to treatment. The study was published in the journal ...
-
NewsNovel lipopeptide produced by bacterium proves lethal against Staphylococcus aureus
A novel antibacterial lipopeptide produced by the bacterium Serratia marcescens has been shown to be highly effective in killing Staphylococcus aureus – one of the most important pathogens occurring in humans.
-
NewsLargest-ever antibiotic discovery effort uses AI to uncover potential cures in microbial dark matter
Researchers used machine learning to search for antibiotics in a vast dataset containing the recorded genomes of tens of thousands of bacteria and other primitive organisms, yielding nearly one million potential antibiotic compounds.
-
NewsThe effect of combinations of antibiotics and natural products on antimicrobial resistance
Thymol, rosemary oil, curcumin, capsicum, and moringa seed extract showed the highest synergistic activity with tested antibiotics against two key pathogens, a new study shows.
-
NewsCinnamon inspires intelligent nanodevice targeting bacteria and other pathogens
Researchers have developed an intelligent nano killer based on a component of cinnamon essential oil (cinnamaldehyde) for use as an antimicrobial agent.
-
NewsThyme essential oil inhibits staph biofilm formation
Thyme essential oil shows efficacy in inhibiting the biofilm formation of Staphylococcus aureus at a concentration of 0.03% (v/v), a new study being presented at Letters in Applied Microbiology ECS Research Symposium has revealed.
